FIELD: medicine, immunology, genetic engineering, pharmacy. SUBSTANCE: invention relates to murine monoclonal anti-idiotypic antibody BR 55-2 Ab2 that is a substitute of antigen Lewis Y6. Antibody is prepared by means of hybridoma technology using conjugate of fragment F(ab')2 JgG63 BR 55-2 of mouse as an antigen. Prepared anti-idiotypic antibody is used for prophylactic or therapeutic immunization against diseases accompanying with expression of antigen Lewis Y6 and as a component in curative- -prophylactic pharmaceutical composition also. Prepared anti-idiotypic antibody is used for quantitative determination of monoclonal antibody with specific binding BR 55-2 and for one-step immunoaffinity purification of variant BR 55-2 of antibody. The usage of invention provides prophylaxis of HIV-infections, cancer of epithelial origin and cancer of lung small cells and their treatment also. EFFECT: improved preparing method, valuable medicinal properties of antibody. 10 cl, 39 dwg, 4 tbl, 23 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIIDIOTYPICAL ANTIBODY FOR ANTIBODIES INHIBITING IMMUNOGLOBULIN BONDING TO ITS HIGH AFFINITY RECEPTOR | 2000 |
|
RU2253655C2 |
ANTIBODIES AGAINST HUMAN IgG1 | 2011 |
|
RU2603284C2 |
ANTIBODIES RAISED TO HUMAN MCP-1 | 2001 |
|
RU2314316C2 |
IL-17 ANTAGONIST ANTIBODIES | 2005 |
|
RU2426741C2 |
HUMAN ANTIBODIES TO IL-β1 | 2001 |
|
RU2286351C2 |
ANTI-IDIOTYPICAL ANTIBODIES THAT INDUCE IMMUNE RESPONSE AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR | 1996 |
|
RU2172636C2 |
APPLICATION OF ANTI-CD40-ANTIBODIES | 2006 |
|
RU2442606C2 |
MONOCLONAL ANTIBODY BINDING WITH HEPATITIS B VIRUS SURFACE ANTIGEN, FAB-FRAGMENT AND METHOD OF DECREASE OF LEVEL OF CIRCULATING SURFACE ANTIGEN OF HEPATITIS B VIRUS ANTIGEN IN PATIENTS | 1992 |
|
RU2146706C1 |
ANTIBODIES TO CD40 FOR USE IN THE TREATMENT OF SJOGREN'S SYNDROME | 2018 |
|
RU2790558C2 |
FUSED POLYPEPTIDE OR ITS SALT, EXPRESSING VECTOR AND PHARMACEUTICAL COMPOSITION DESIGNATED FOR TREATMENT OF IGE-MEDIATED DISEASES | 1997 |
|
RU2209211C2 |
Authors
Dates
2003-07-20—Published
1993-05-14—Filed